# Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions

> **NCT02327247** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Felodipine
- **DRUG:** PLENDIL®

## Key facts

- **NCT ID:** NCT02327247
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327247, "Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02327247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*